title: Influenza matrix protein 2 alters CFTR expression and function through its ion channel activity.
abstract: The human cystic fibrosis transmembrane conductance regulator (CFTR) is a cyclic AMP-activated chloride (Cl(-)) channel in the lung epithelium that helps regulate the thickness and composition of the lung epithelial lining fluid. We investigated whether influenza M2 protein, a pH-activated proton (H(+)) channel that traffics to the plasma membrane of infected cells, altered CFTR expression and function. M2 decreased CFTR activity in 1) Xenopus oocytes injected with human CFTR, 2) epithelial cells (HEK-293) stably transfected with CFTR, and 3) human bronchial epithelial cells (16HBE14o-) expressing native CFTR. This inhibition was partially reversed by an inhibitor of the ubiquitin-activating enzyme E1. Next we investigated whether the M2 inhibition of CFTR activity was due to an increase of secretory organelle pH by M2. Incubation of Xenopus oocytes expressing CFTR with ammonium chloride or concanamycin A, two agents that alkalinize the secretory pathway, inhibited CFTR activity in a dose-dependent manner. Treatment of M2- and CFTR-expressing oocytes with the M2 ion channel inhibitor amantadine prevented the loss in CFTR expression and activity; in addition, M2 mutants, lacking the ability to transport H(+), did not alter CFTR activity in Xenopus oocytes and HEK cells. Expression of an M2 mutant retained in the endoplasmic reticulum also failed to alter CFTR activity. In summary, our data show that M2 decreases CFTR activity by increasing secretory organelle pH, which targets CFTR for destruction by the ubiquitin system. Alteration of CFTR activity has important consequences for fluid regulation and may potentially modify the immune response to viral infection.
authors: Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35205, USA.
authors: James D
authors: JD
authors: Londino
authors: Ahmed
authors: A
authors: Lazrak
authors: Asta
authors: A
authors: Jurkuvenaite
authors: James F
authors: JF
authors: Collawn
authors: James W
authors: JW
authors: Noah
authors: Sadis
authors: S
authors: Matalon
mesh_terms: D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000096:biosynthesis / Q000502:physiology*; D005663:Furans / Q000494:pharmacology; D057809:HEK293 Cells; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007473:Ion Channels / Q000187:drug effects / Q000502:physiology*; D009865:Oocytes / Q000378:metabolism; D018408:Patch-Clamp Techniques; D011720:Pyrazoles / Q000494:pharmacology; D055571:Secretory Pathway / Q000187:drug effects; D044764:Ubiquitin-Activating Enzymes / Q000037:antagonists & inhibitors; D014763:Viral Matrix Proteins / Q000494:pharmacology*; D014981:Xenopus; D000086082:Viroporin Proteins
chemical_list: D000547:Amantadine; D001565:Benzoates; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D005663:Furans; D007473:Ion Channels; D011720:Pyrazoles; D044764:Ubiquitin-Activating Enzymes; D014763:Viral Matrix Proteins; C523934:4(4-(5-nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl)-benzoic acid ethyl ester; C488937:M2 protein, Influenza A virus; D000086082:Viroporin Proteins
keywords: 16HBE14o-; Xenopus oocytes; patch clamp; secretory pH; ubiquitin